| Product Code: ETC10772556 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Peripheral Intervention Drug-Eluting Devices Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Peripheral Intervention Drug-Eluting Devices Market - Industry Life Cycle |
3.4 Netherlands Peripheral Intervention Drug-Eluting Devices Market - Porter's Five Forces |
3.5 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.6 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2021 & 2031F |
3.7 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Netherlands Peripheral Intervention Drug-Eluting Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of peripheral artery disease in the Netherlands |
4.2.2 Technological advancements in drug-eluting devices for peripheral interventions |
4.2.3 Growing demand for minimally invasive procedures in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-eluting devices |
4.3.2 High cost associated with drug-eluting devices compared to traditional interventions |
4.3.3 Limited awareness among healthcare professionals about the benefits of drug-eluting devices |
5 Netherlands Peripheral Intervention Drug-Eluting Devices Market Trends |
6 Netherlands Peripheral Intervention Drug-Eluting Devices Market, By Types |
6.1 Netherlands Peripheral Intervention Drug-Eluting Devices Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Device Type, 2021 - 2031F |
6.1.3 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Stents, 2021 - 2031F |
6.1.4 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Balloons, 2021 - 2031F |
6.1.5 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Stents, 2021 - 2031F |
6.1.6 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Based Stents, 2021 - 2031F |
6.1.7 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hybrid Coated Stents, 2021 - 2031F |
6.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market, By Coating Material |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sirolimus, 2021 - 2031F |
6.2.3 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Paclitaxel, 2021 - 2031F |
6.2.4 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Everolimus, 2021 - 2031F |
6.2.5 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Zotarolimus, 2021 - 2031F |
6.2.6 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Rapamycin, 2021 - 2031F |
6.3 Netherlands Peripheral Intervention Drug-Eluting Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Peripheral Artery Disease, 2021 - 2031F |
6.3.3 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Chronic Limb Ischemia, 2021 - 2031F |
6.3.4 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.5 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Aneurysm Repair, 2021 - 2031F |
6.3.6 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Stenosis Treatment, 2021 - 2031F |
6.4 Netherlands Peripheral Intervention Drug-Eluting Devices Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Ambulatory Centers, 2021 - 2031F |
6.4.5 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Cardiac Care Centers, 2021 - 2031F |
6.5 Netherlands Peripheral Intervention Drug-Eluting Devices Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Nanocoating, 2021 - 2031F |
6.5.3 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Coating, 2021 - 2031F |
6.5.4 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sustained Drug Release, 2021 - 2031F |
6.5.5 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Encapsulated, 2021 - 2031F |
6.5.6 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031F |
7 Netherlands Peripheral Intervention Drug-Eluting Devices Market Import-Export Trade Statistics |
7.1 Netherlands Peripheral Intervention Drug-Eluting Devices Market Export to Major Countries |
7.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Imports from Major Countries |
8 Netherlands Peripheral Intervention Drug-Eluting Devices Market Key Performance Indicators |
8.1 Adoption rate of drug-eluting devices in peripheral interventions |
8.2 Number of clinical studies and trials supporting the efficacy of drug-eluting devices |
8.3 Rate of reimbursement coverage for drug-eluting devices in the Netherlands |
9 Netherlands Peripheral Intervention Drug-Eluting Devices Market - Opportunity Assessment |
9.1 Netherlands Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Coating Material, 2021 & 2031F |
9.3 Netherlands Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Netherlands Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Netherlands Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Netherlands Peripheral Intervention Drug-Eluting Devices Market - Competitive Landscape |
10.1 Netherlands Peripheral Intervention Drug-Eluting Devices Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Peripheral Intervention Drug-Eluting Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here